- Home
- MNSO vs JAZZ Comparison
MNSO vs JAZZ Comparison
Compare MNSO & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSO
- JAZZ
- Stock Information
- Founded
- MNSO 2013
- JAZZ 2003
- Country
- MNSO China
- JAZZ Ireland
- Employees
- MNSO N/A
- JAZZ N/A
- Industry
- MNSO Department/Specialty Retail Stores
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- MNSO Consumer Discretionary
- JAZZ Health Care
- Exchange
- MNSO Nasdaq
- JAZZ Nasdaq
- Market Cap
- MNSO 7.8B
- JAZZ 7.3B
- IPO Year
- MNSO 2020
- JAZZ 2007
- Fundamental
- Price
- MNSO $23.88
- JAZZ $121.43
- Analyst Decision
- MNSO Hold
- JAZZ Buy
- Analyst Count
- MNSO 4
- JAZZ 14
- Target Price
- MNSO $20.90
- JAZZ $173.93
- AVG Volume (30 Days)
- MNSO 1.1M
- JAZZ 567.6K
- Earning Date
- MNSO 03-11-2025
- JAZZ 02-26-2025
- Dividend Yield
- MNSO 2.37%
- JAZZ N/A
- EPS Growth
- MNSO 2.83
- JAZZ 458.10
- EPS
- MNSO 1.23
- JAZZ 7.04
- Revenue
- MNSO $2,501,784,871.00
- JAZZ $3,992,712,000.00
- Revenue This Year
- MNSO $14.75
- JAZZ $7.51
- Revenue Next Year
- MNSO $22.00
- JAZZ $6.84
- P/E Ratio
- MNSO $19.11
- JAZZ $17.18
- Revenue Growth
- MNSO 9.45
- JAZZ 5.23
- 52 Week Low
- MNSO $12.51
- JAZZ $99.06
- 52 Week High
- MNSO $27.71
- JAZZ $134.17
- Technical
- Relative Strength Index (RSI)
- MNSO 51.73
- JAZZ 47.48
- Support Level
- MNSO $22.85
- JAZZ $118.72
- Resistance Level
- MNSO $23.83
- JAZZ $124.66
- Average True Range (ATR)
- MNSO 0.83
- JAZZ 2.79
- MACD
- MNSO -0.31
- JAZZ -0.24
- Stochastic Oscillator
- MNSO 26.06
- JAZZ 39.45
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.